Market revenue in 2023 | USD 389.9 million |
Market revenue in 2030 | USD 727.9 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro toxicology testing market will help companies and investors design strategic landscapes.
Pharmaceutical industry was the largest segment with a revenue share of 40.55% in 2023. Horizon Databook has segmented the Norway in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as stringent regulatory guidelines for preventing animal testing, increasing demand for toxicological testing procedures, and technological advancements for developing sophisticated & accurate toxicology testing methods are projected to drive the in-vitro toxicology testing market in the country.
Moreover, several investments from market players owing to growing biotechnology and pharmaceutical sectors in the country have propelled the market growth to a significant extent. For instance, in June 2022 FUJIFILM Corporation announced an investment of USD 1.6 billion to expand and enhance its global offering of cell culture manufacturing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway in-vitro toxicology testing market , including forecasts for subscribers. This country databook contains high-level insights into Norway in-vitro toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account